Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.7, 2013-10, pp. : 811-827

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanomedicine: A New Frontier in Cancer Therapeutics

Current Drug Delivery, Vol. 8, Iss. 3, 2011-05 ,pp. : 245-253

Bentham Science Publishers

Access to resources Recommend Favorite

SIRT1: new avenues of discovery for disorders of oxidative stress

By Chong Zhao Zhong Shang Yan Chen Wang Shaohui Maiese Kenneth

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 167-178

Informa Healthcare

Access to resources Recommend Favorite

Advances in Cancer Therapeutics and Patient Access to New Drugs

By Dranitsaris George

PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. : 213-224

Adis International

Access to resources Recommend Favorite

Quassinoids: From Traditional Drugs to New Cancer Therapeutics

Current Medicinal Chemistry, Vol. 18, Iss. 3, 2011-01 ,pp. : 316-328

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors

Current Pharmaceutical Design, Vol. 20, Iss. 15, 2014-05 ,pp. : 2637-2647

Bentham Science Publishers

Access to resources Recommend Favorite